Analogic (ALOG) Issues FY18 Earnings Guidance
Analogic (NASDAQ:ALOG) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $2.75-2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.81. The company issued revenue guidance of $450-460 million, compared to the consensus revenue estimate of $452.00 million.
A number of analysts have issued reports on the company. Zacks Investment Research raised Analogic from a hold rating to a buy rating and set a $93.00 target price for the company in a research note on Tuesday, October 10th. Jefferies Group reaffirmed a hold rating and issued a $75.00 target price on shares of Analogic in a research note on Wednesday, September 20th. Four equities research analysts have rated the stock with a hold rating, Analogic presently has an average rating of Hold and an average price target of $85.25.
Shares of Analogic (NASDAQ:ALOG) traded down $0.55 during trading hours on Wednesday, hitting $81.05. The company had a trading volume of 47,300 shares, compared to its average volume of 94,605. The firm has a market cap of $1,018.75, a P/E ratio of 48.57, a price-to-earnings-growth ratio of 4.16 and a beta of 0.86. Analogic has a 1 year low of $66.00 and a 1 year high of $91.40.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.